Literature DB >> 10456977

Pulmonary hypertension secondary to neurofibromatosis: intimal fibrosis versus thromboembolism.

N Samuels1, N Berkman, E Milgalter, J Bar-Ziv, G Amir, M R Kramer.   

Abstract

Neurofibromatosis has been known to involve blood vessels throughout the body. Pulmonary involvement with interstitial fibrosing alveolitis has been described but no case of pulmonary vascular involvement has been reported to date. A 51 year old patient with cutaneous neurofibromatosis is described who presented with severe pulmonary hypertension and radiographic, scintigraphic, and angiographic evidence of chronic thromboembolic pulmonary hypertension. Severe intimal fibrosis consistent with vascular involvement with neurofibromatosis was found on endarterectomy with no evidence of pulmonary thromboembolism. Neurofibromatosis of pulmonary arteries should be considered as a possible cause of pulmonary hypertension.

Entities:  

Mesh:

Year:  1999        PMID: 10456977      PMCID: PMC1745562          DOI: 10.1136/thx.54.9.858

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  4 in total

1.  Type 1 neurofibromatosis and pulmonary hypertension: a report of two cases and a review.

Authors:  Amit Malviya; Sundeep Mishra; Shyam S Kothari
Journal:  Heart Asia       Date:  2012-01-01

Review 2.  Pulmonary Hypertension and Cancer: Etiology, Diagnosis, and Management.

Authors:  Fatima A Ballout; Ahmad S Manshad; Tochukwu M Okwuosa
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-06

3.  Pulmonary arterial hypertension associated with neurofibromatosis type 1.

Authors:  Miguel F Carrascosa; Isabel Celemín Larroque; Juan-Luis García Rivero; José-Antonio Saiz-Quevedo García; Marta Cano Hoz; Miguel Ares Ares; Xabier Arrastio López; José-Ramón Salcines Caviedes
Journal:  BMJ Case Rep       Date:  2010-11-29

4.  Severe dyspnea in a patient with neurofibromatosis type 1.

Authors:  P B Poble; J C Dalphin; B Degano
Journal:  Respir Med Case Rep       Date:  2017-06-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.